When to Start ART in the Setting of Acute AIDS-Related Opportunistic Infections: The Time Is Now!
Authors:
- 26 June 2012
- journal article
- review article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 9 (3) , 251-258
Abstract
Despite the substantial benefits of combination antiretroviral therapy (ART), a significant proportion of HIV-infected individuals still present with advanced disease and active AIDS-related opportunistic infections (OIs). The weight of evidence from recent studies supports the early initiation of ART (ie, within 2 weeks of initiating treatment for the acute OIs). Initiating ART early in acutely ill patients can reduce AIDS-related progression and death. Early ART has not been associated with increased rates of immune reconstitution inflammatory syndrome in prospective studies of non-tuberculosis OIs, although this concern is frequently cited as a reason to delay ART. Nor has early ART been associated with increased adverse outcomes. Nonetheless, initiating ART early in acute care settings can be challenging to implement and requires a well-coordinated multidisciplinary team with expertise in ART management.Keywords
This publication has 45 references indexed in Scilit:
- Integration of Antiretroviral Therapy with Tuberculosis TreatmentNew England Journal of Medicine, 2011
- Timing of Antiretroviral Therapy for HIV-1 Infection and TuberculosisNew England Journal of Medicine, 2011
- The Effect of AIDS Clinical Trials Group Protocol 5164 on the Time From Pneumocystis jirovecii Pneumonia Diagnosis to Antiretroviral Initiation in Routine Clinical Practice: A Case Study of Diffusion, Dissemination, and ImplementationClinical Infectious Diseases, 2011
- Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections: A Cost-Effectiveness Analysis of ACTG A5164HIV Research & Clinical Practice, 2010
- Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited SettingsClinical Infectious Diseases, 2010
- Late Presentation for Human Immunodeficiency Virus Care in the United States and CanadaClinical Infectious Diseases, 2010
- Worldwide mortality in men and women aged 15–59 years from 1970 to 2010: a systematic analysisThe Lancet, 2010
- Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV‐associated cryptococcal meningitis‐infected patientsHIV Medicine, 2010
- High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll outAIDS, 2009
- Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceAIDS, 2008